NAMPT/IDO1-IN-1

CAS: 2247884-06-4 F: C23H24BrFN8O3 W: 559.39

NAMPT/IDO1-IN-1 is an orally active dual inhibitor of NAMPT and IDO1 with IC50s of 57.7 nM and 233 nM, respectively. NAM

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	NAMPT/IDO1-IN-1 is an orally active dual inhibitor of NAMPT and IDO1 with IC50s of 57.7 nM and 233 nM, respectively. NAMPT/IDO1-IN-1 blocks NAD+ biosynthesis, inhibits proliferation and migration of Paclitaxel (HY-B0015)- and FK866 (HY-50876)-resistant NSCLC cell lines (A549/R cells). NAMPT/IDO1-IN-1 has shown antitumor effects in mice and enhanced A549/R cell sensitivity to paclitaxel[1].
Invitro	NAMPT/IDO1-IN-1 (化合物 10e) (10 μM; 48 h) 对 A549/R 细胞具有抗增殖活性，并依赖于 NAMPT 和 IDO1[1]。NAMPT/IDO1-IN-1 (5 μM, 10 μM, 15 μM; 12 d) 抑制 A549/R 细胞的集落形成，并以剂量依赖的方式促进细胞内 ROS 的积累[1]。NAMPT/IDO1-IN-1 (10 μM; 24 h) 以 NAMPT 和 IDO1 依赖的方式减少 A549/R 细胞中的 NAD+[1]。
In Vivo	NAMPT/IDO1-IN-1 (化合物 10e) (5 μM; 24 h) 对斑马鱼胚胎的 ROS 有促进作用，其 ROS 水平远高于 LPS (50 μg/mL) 处理[1]。NAMPT/IDO1-IN-1 (25 mg/kg; 口服; 单次剂量) 具有良好的口服生物利用度和 (5 mg/kg; 静脉注射; 单次剂量) 显示出中等整体暴露度[1]。NAMPT/IDO1-IN-1 (50、100、200 mg/kg; 口服; 每天 2 次, 共 3 周) 在 A549/R 肿瘤异种移植模型中也显示出体内抗肿瘤作用[1]。 Animal Model:
Name	NAMPT/IDO1-IN-1
CAS	2247884-06-4
Formula	C23H24BrFN8O3
Molar Mass	559.39
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Reference	[1]. Wang K, et al. Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer. J Med Chem. 2023 Jan 12;66(1):1027-1047.